Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy
- Conditions
- Breast Cancer
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00074100
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Conditions
- Gastric Cancer
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2012-02-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00074009
- Locations
- 🇺🇸
Queens Cancer Center of Queens Hospital, Jamaica, New York, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2003-12-02
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00003426
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2003-11-25
- Last Posted Date
- 2013-06-27
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00003037
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2003-11-24
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00002828
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2003-11-21
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00036920
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer
- Conditions
- Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2003-11-13
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00017017
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
- Conditions
- Prostate CancerThromboembolism
- First Posted Date
- 2003-11-13
- Last Posted Date
- 2013-01-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00014352
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
- Conditions
- Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2003-11-11
- Last Posted Date
- 2013-06-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00012090
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
- Conditions
- Neuroblastoma
- Interventions
- Biological: anti-GD2 murine IgG3 monoclonal antibody 3F8
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2022-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 291
- Registration Number
- NCT00072358
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States